56S1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sartorius Stedim Biotech SA

Watchlist Manager

Watchlist

Price: 208.4 EUR -3.07% Market Closed

Market Cap: €20.3B

	Sartorius Stedim Biotech SA F:56S1	FR
C	Coca-Cola Femsa SAB de CV F:CFSL	MX
X	Xenon Pharmaceuticals Inc F:XP0	CA
	Upland Software Inc NASDAQ:UPLD	US
S	STAAR Surgical Co SWB:SR3	US
	Progressive Planet Solutions Inc XTSX:PLAN	CA
B	Baylin Technologies Inc F:5BT	CA
A	AeroVironment Inc F:JPX	US
S	Shanghai Jin Jiang Online Network Service Co Ltd SSE:900914	CN
	Fintech SA F:9DZ	PL
R	Rockwell Medical Inc F:RWM	US
D	De Licacy Industrial Co Ltd TWSE:1464	TW

Profitability Summary

Sartorius Stedim Biotech SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

45%

Sustainable 3Y Average Gross Margin

44%

Declining Gross Margin

49% > 45%

Healthy Operating Margin

19%

Sustainable 3Y Average Operating Margin

16%

Declining Operating Margin

19% > 19%

Low Net Margin

10%

Low 3Y Average Net Margin

Declining Net Margin

15% > 10%

Exceptional Free Cash Flow Margin

13%

Strong 3Y Average Free Cash Flow Margin

13%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.